ArticleFrontiers in oncology2026

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in operable breast cancer patients with hormone receptor-positive, HER2-negative.

Yirui Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.